Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy

Clinical characteristics and treatment related toxicities

Carolyn R. Freeman, Pierre M. Bourgouin, R. Alex Sanford, Michael E. Cohen, Henry S. Friedman, Larry E. Kun

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

BACKGROUND. Over the past decade, the principal focus of research in pediatric brain stem gliomas has been on the use of hyperfractionated radiotherapy (HRT). The purpose of this study was to evaluate the clinical characteristics and treatment related toxicities of long term survivors of HRT treatment. METHODS. Of the 130 children with brain stem tumors treated with escalating doses of HRT on Pediatric Oncology Group (POG) 8495, there are only 9 long term survivors. Prospectively collected data, including flow sheets and all pretreatment and follow-up radiologic studies, were reviewed for these patients. Additional information was requested from the treating institutions with regard to sequelae of treatment. RESULTS. Clinical characteristics (including age, sex, duration of symptoms, and presenting signs) for the nine surviving patients were not different from the total population of patients treated on POG 8495. Pretreatment imaging, however, revealed that only four of the nine patients had typical diffuse intrinsic pontine lesions and, conversely, that at least three of the nine patients had lesions that would now be considered relatively favorable. Complete information regarding treatment related toxicity was available for eight patients, only one of whom is without sequelae. Seven have schooling difficulties, two have a seizure disorder, five have hearing loss, and two have required growth hormone replacement. Follow-up imaging findings were striking in four of the eight patients because of white matter changes consistent with leukoencephalopathy (two patients), diffuse microhemorrhages (one patient), and dystrophic calcification (one patient) in the radiation field. CONCLUSIONS. The high frequency of treatment related sequelae in long term survivors of HRT suggests a need for caution in the use of HRT, particularly in patients who have brain stem tumors with a more favorable prognosis.

Original languageEnglish (US)
Pages (from-to)555-562
Number of pages8
JournalCancer
Volume77
Issue number3
DOIs
StatePublished - Feb 1 1996

Fingerprint

Glioma
Brain Stem
Survivors
Radiotherapy
Therapeutics
Brain Stem Neoplasms
Pediatrics
Leukoencephalopathies
Hearing Loss
Growth Hormone
Signs and Symptoms
Epilepsy
Radiation

Keywords

  • brain stem tumors
  • hyperfractionated radiotherapy
  • radiotherapy
  • treatment

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy : Clinical characteristics and treatment related toxicities. / Freeman, Carolyn R.; Bourgouin, Pierre M.; Sanford, R. Alex; Cohen, Michael E.; Friedman, Henry S.; Kun, Larry E.

In: Cancer, Vol. 77, No. 3, 01.02.1996, p. 555-562.

Research output: Contribution to journalArticle

Freeman, Carolyn R. ; Bourgouin, Pierre M. ; Sanford, R. Alex ; Cohen, Michael E. ; Friedman, Henry S. ; Kun, Larry E. / Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy : Clinical characteristics and treatment related toxicities. In: Cancer. 1996 ; Vol. 77, No. 3. pp. 555-562.
@article{bf94bc298d414d32a395bb4b74c9529c,
title = "Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy: Clinical characteristics and treatment related toxicities",
abstract = "BACKGROUND. Over the past decade, the principal focus of research in pediatric brain stem gliomas has been on the use of hyperfractionated radiotherapy (HRT). The purpose of this study was to evaluate the clinical characteristics and treatment related toxicities of long term survivors of HRT treatment. METHODS. Of the 130 children with brain stem tumors treated with escalating doses of HRT on Pediatric Oncology Group (POG) 8495, there are only 9 long term survivors. Prospectively collected data, including flow sheets and all pretreatment and follow-up radiologic studies, were reviewed for these patients. Additional information was requested from the treating institutions with regard to sequelae of treatment. RESULTS. Clinical characteristics (including age, sex, duration of symptoms, and presenting signs) for the nine surviving patients were not different from the total population of patients treated on POG 8495. Pretreatment imaging, however, revealed that only four of the nine patients had typical diffuse intrinsic pontine lesions and, conversely, that at least three of the nine patients had lesions that would now be considered relatively favorable. Complete information regarding treatment related toxicity was available for eight patients, only one of whom is without sequelae. Seven have schooling difficulties, two have a seizure disorder, five have hearing loss, and two have required growth hormone replacement. Follow-up imaging findings were striking in four of the eight patients because of white matter changes consistent with leukoencephalopathy (two patients), diffuse microhemorrhages (one patient), and dystrophic calcification (one patient) in the radiation field. CONCLUSIONS. The high frequency of treatment related sequelae in long term survivors of HRT suggests a need for caution in the use of HRT, particularly in patients who have brain stem tumors with a more favorable prognosis.",
keywords = "brain stem tumors, hyperfractionated radiotherapy, radiotherapy, treatment",
author = "Freeman, {Carolyn R.} and Bourgouin, {Pierre M.} and Sanford, {R. Alex} and Cohen, {Michael E.} and Friedman, {Henry S.} and Kun, {Larry E.}",
year = "1996",
month = "2",
day = "1",
doi = "10.1002/(SICI)1097-0142(19960201)77:3<555::AID-CNCR19>3.0.CO;2-3",
language = "English (US)",
volume = "77",
pages = "555--562",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy

T2 - Clinical characteristics and treatment related toxicities

AU - Freeman, Carolyn R.

AU - Bourgouin, Pierre M.

AU - Sanford, R. Alex

AU - Cohen, Michael E.

AU - Friedman, Henry S.

AU - Kun, Larry E.

PY - 1996/2/1

Y1 - 1996/2/1

N2 - BACKGROUND. Over the past decade, the principal focus of research in pediatric brain stem gliomas has been on the use of hyperfractionated radiotherapy (HRT). The purpose of this study was to evaluate the clinical characteristics and treatment related toxicities of long term survivors of HRT treatment. METHODS. Of the 130 children with brain stem tumors treated with escalating doses of HRT on Pediatric Oncology Group (POG) 8495, there are only 9 long term survivors. Prospectively collected data, including flow sheets and all pretreatment and follow-up radiologic studies, were reviewed for these patients. Additional information was requested from the treating institutions with regard to sequelae of treatment. RESULTS. Clinical characteristics (including age, sex, duration of symptoms, and presenting signs) for the nine surviving patients were not different from the total population of patients treated on POG 8495. Pretreatment imaging, however, revealed that only four of the nine patients had typical diffuse intrinsic pontine lesions and, conversely, that at least three of the nine patients had lesions that would now be considered relatively favorable. Complete information regarding treatment related toxicity was available for eight patients, only one of whom is without sequelae. Seven have schooling difficulties, two have a seizure disorder, five have hearing loss, and two have required growth hormone replacement. Follow-up imaging findings were striking in four of the eight patients because of white matter changes consistent with leukoencephalopathy (two patients), diffuse microhemorrhages (one patient), and dystrophic calcification (one patient) in the radiation field. CONCLUSIONS. The high frequency of treatment related sequelae in long term survivors of HRT suggests a need for caution in the use of HRT, particularly in patients who have brain stem tumors with a more favorable prognosis.

AB - BACKGROUND. Over the past decade, the principal focus of research in pediatric brain stem gliomas has been on the use of hyperfractionated radiotherapy (HRT). The purpose of this study was to evaluate the clinical characteristics and treatment related toxicities of long term survivors of HRT treatment. METHODS. Of the 130 children with brain stem tumors treated with escalating doses of HRT on Pediatric Oncology Group (POG) 8495, there are only 9 long term survivors. Prospectively collected data, including flow sheets and all pretreatment and follow-up radiologic studies, were reviewed for these patients. Additional information was requested from the treating institutions with regard to sequelae of treatment. RESULTS. Clinical characteristics (including age, sex, duration of symptoms, and presenting signs) for the nine surviving patients were not different from the total population of patients treated on POG 8495. Pretreatment imaging, however, revealed that only four of the nine patients had typical diffuse intrinsic pontine lesions and, conversely, that at least three of the nine patients had lesions that would now be considered relatively favorable. Complete information regarding treatment related toxicity was available for eight patients, only one of whom is without sequelae. Seven have schooling difficulties, two have a seizure disorder, five have hearing loss, and two have required growth hormone replacement. Follow-up imaging findings were striking in four of the eight patients because of white matter changes consistent with leukoencephalopathy (two patients), diffuse microhemorrhages (one patient), and dystrophic calcification (one patient) in the radiation field. CONCLUSIONS. The high frequency of treatment related sequelae in long term survivors of HRT suggests a need for caution in the use of HRT, particularly in patients who have brain stem tumors with a more favorable prognosis.

KW - brain stem tumors

KW - hyperfractionated radiotherapy

KW - radiotherapy

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=0030024163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030024163&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0142(19960201)77:3<555::AID-CNCR19>3.0.CO;2-3

DO - 10.1002/(SICI)1097-0142(19960201)77:3<555::AID-CNCR19>3.0.CO;2-3

M3 - Article

VL - 77

SP - 555

EP - 562

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3

ER -